Microbial metabolism. Part 14. Isolation and bioactivity evaluation of microbial metabolites of resveratrol

Natural Product Research

Volumn 27, Issue 16, 2013, Pages 1437-1444

  Herath, Wimal ^a   Iqrar Khan, Shabana ^a   Ahmad Khan, Ikhlas ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

Beauveria bassiana; Microbial metabolism; Penicillium chrysogenium; Resveratrol

Indexed keywords

5 METHOXYRESVERATROL 3 O BETA GLUCOSIDE; 5 METHOXYRESVERATROL 3 O SULFATE; DRUG METABOLITE; HYDROXYL GROUP; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; RESVERATROL; RESVERATROL 3 O SULFATE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BEAUVERIA BASSIANA; BIOLOGICAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; MICROBIAL METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PENICILLIUM CHRYSOGENUM;

BEAUVERIA; GLUCOSIDES; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR STRUCTURE; PENICILLIUM CHRYSOGENUM; STILBENES;

EID: 84884258015     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2012.722089     Document Type: Article

References (28)

1. Agrawal, P.K., (Ed.), &Bansal, M.C. (1989). Carbon-13 NMR of flavonoids (Chap. 6, pp. 168-171, 286-293). Amsterdam: Elsevier.
2. Agrawal, P., Halaweish, F., &Dwivedi, C. (2007). Antioxidant effects and drug interactions of resveratrol present in wine. Journal of Wine Research, 18, 59-71.
3. Chu, X., Sun, A., &Liu, R. (2005). Preparative isolation and purification of five compounds from the Chinese medicinal herb Polygonum cuspidatum Sieb. et Zucc by high-speed counter-current chromatography. Journal of Chromatography A, 1097, 33-39.
4. Chun, Y.J., Ryu, S.Y., Jeong, T.C.T., &Kim, M.Y. (2001). Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metabolism and Disposition, 29, 389-393.
5. Clark, A.M., McChesney, J.D., &Hufford, C.D. (1985). The use of microorganisms for the study of drug metabolism. Medicinal Research Reviews, 5, 231-253.
6. Herath, W.H.M.W., Ferreira, F., &Khan, I.A. (2003). Microbial transformation of xanthohumol. Phytochemistry, 62, 673-677.
7. Hoshino, J., Park, E., Kondratyuk, T.P., Marler, L., Pezzuto, J.M., van Breemen, R.B., . . . Cushman, M. (2010). Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. Journal of Medicinal Chemistry, 53, 5033-5043.
8. Juan, M.E., Maijó , M., &Planas, J.M. (2010). Quantification of trans-resvertrol and its metabolites in rat plasma and tissues by HPLC. Journal of Pharmaceutical and Biomedical Analysis, 51, 391-398.
9. Kaldas, M.I., Walle, U.K., &Walle, T. (2003). Resveratrol transport and metabolism by human intestinal Caco- 2 cells. Journal of Pharmacy and Pharmacology, 55, 307-312.
10. Kraft, T.E., Parisotto, D., Schempp, C., &Efferth, T. (2009). Fighting cancer with red wine? Molecular mechanisms of resveratrol. Critical Reviews in Food Science and Nutrition, 49, 782-799.
11. Kundu, J.K., &Surh, Y.-J. (2008). Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Letters, 269, 243-261.
12. Liu, X., Teng, Z., Zhang, Y., Huan, M., &Zhou, S. (2010). High performance liquid chromatography-tandem mass spectrometric determination of resveratrol and its metabolites in rat tissue. Analytical Letters, 43, 557-569.
13. Miksits, M., Wlcek, K., Svoboda, M., Kunert, O., Haslinger, E., Thalhammer, T., . . . Jaeger, W. (2009). Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells. Planta Medica, 75, 1227-1230.
14. Miksits, M., Wlcek, K., Svoboda, M., Thalhammer, T., Ellinger, I., Stefanzl, G., . . . Jaeger, W. (2010). Expression of sulfotransferases and sulfatases in human breast cancer: Impact on resveratrol metabolism. Cancer Letters, 289, 237-245.
15. Mizutani, K., Ikeda, K., &Yamori, Y. (2000). Resveratrol inhibits AGEs-induced proliferation and collagen synthesis activity in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats. Biochemical Biophysical Research Communications, 274, 61-67.
16. Orsini, F., Pelizzoni, F., Verotta, L., &Aburjai, T. (1997). Isolation, synthesis, and antiplatelet aggregation activity of resveratrol 3-O-D-glucopyranoside and related compounds. Journal of Natural Products, 60, 1082-1087.
17. Pirola, L., &Frö jdö , S. (2008). Resveratrol: One molecule, many targets. Life, 60, 323-332.
18. Rosazza, P.N., &Duffel, M.W. (1986). Metabolic transformations of alkaloids. In A. Brossi (Ed.), Alkaloid chemistry and pharmacology (Vol. 27, pp. 391-392). New York: Academic Press.
19. Shankar, S., Singh, G., &Sirivastava, R.K. (2007). Chemoprevention by resveratrol: Molecular mechanisms and therapeutic potential. Frontiers in Bioscience, 12, 4839-4854.
20. Slade, D., Galal, A.M., Gul, W., Radwan, M.M., Ahmed, S.A., Khan, S.I., . . . ElSohly, M.A. (2009). Antiprotozoal, anticancer and antimicrobial activities of dihydroartemisinin acetal dimers and monomers. Bioorganic and Medicinal Chemistry, 17, 7949-7957.
21. Sobolev, V.S., Khan, S.K., Tabanca, N., Wedge, D.E., Susan, P.M., Cutler, S.T., . . . Gloer, J.B. (2011). Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic stilbenoids. Journal of Agricultural and Food Chemistry, 59, 1673-1682.
22. Soleas, G.J., Diamandis, E.P., &Goldberg, D.M. (1997). Resveratrol: A molecule whose time has come? And gone? Clinical Biochemistry, 30, 91-113.
23. Stivala, L.A., Savio, M., Carafoli, F., Perucca, P., Bianchi, L., Maga, G., . . . Vannini, V. (2001). Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. Journal of Biological Chemistry, 276, 22586-22594.
24. Tosun,I., &Inkaya, A.N. (2010). Resveratrol as a health and disease benefit agent. Food Reviews International, 26, 85-101.
25. Walle, T., Hsieh, F., DeLegge, M.H., Oatis Jr, J.E., &Walle, U.K. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition, 32, 1377-1382.
26. Wenzel, E., &Somoza, V. (2005). Metabolism and bioavailability of trans-resveratrol. Molecular Nutrition and Food Research, 49, 472-481.
27. Yang, H., Sung, S.H., &Kim, Y.C. (2005). Two new hepatoprotective stilbene glycosides from Acer mono leaves. Journal Natural Products, 68, 101-103.
28. Yu, C., Shin, Y.G., Chow, A., Li, Y., Kosmeder, J.W., Lee, Y.S., . . . van Breemen, R.B. (2002). Human, rat, and mouse metabolism of resveratrol. Pharmaceutical Research, 19, 1907-1913.